18.9 C
Saturday, July 13, 2024

Illumina faces record European Union fine over Grail deal next week – report

Must read

- Advertisement -

Illumina headquarters in Silicon Valley

Sundry Photography/iStock Editorial via Getty Images

Illumina (NASDAQ:ILMN) faces a record fine from the European Union as early as next week after completing its purchase of cancer-screening company Grail without the antitrust regulator’s approval.

The fine may be as much as $453 million, or 10% of the company’s revenue, according

- Advertisement -

Source link

- Advertisement -

More articles


Please enter your comment!
Please enter your name here

Latest article